John Yu
Algemeen Directeur bij Kairos Pharma Ltd.
Profiel
Dr. John S.
Yu, MD, is a Chairman & Chief Executive Officer at Kairos Pharma Ltd.
and a Director-Surgical Neuro Oncology at Cedars-Sinai Medical Center.
Dr. Yu also served on the board at ImmunoCellular Therapeutics Ltd.
He received his undergraduate degree from Stanford University, a graduate degree from Harvard University and a doctorate degree from Harvard Medical School.
Actieve functies van John Yu
| Bedrijven | Functie | Begin |
|---|---|---|
Kairos Pharma Ltd.
 Kairos Pharma Ltd. Pharmaceuticals: MajorHealth Technology Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA. | Algemeen Directeur | 17-06-2013 |
Cedars-Sinai Medical Center
 Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01-01-1998 |
Eerdere bekende functies van John Yu
| Bedrijven | Functie | Einde |
|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Oprichter | - |
Opleiding van John Yu
| Stanford University | Undergraduate Degree |
| Harvard University | Graduate Degree |
| Harvard Medical School | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
 | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center Hospital/Nursing ManagementHealth Services Cedars-Sinai Medical Center operates a hospital that provides healthcare services. It specializes in cancer, endocrinology, gynecology, neurology, orthopedics, and respiratory disorders. The company was founded in 1902 and is headquartered in Los Angeles, CA. | Health Services |
